311 related articles for article (PubMed ID: 8264800)
21. Growth phase-dependent regulation and membrane localization of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin.
Gutowski-Eckel Z; Klein C; Siegers K; Bohm K; Hammelmann M; Entian KD
Appl Environ Microbiol; 1994 Jan; 60(1):1-11. PubMed ID: 8117069
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of Nonproteinogenic Amino Acids in Class I and II Lantibiotics.
Kakkar N; Perez JG; Liu WR; Jewett MC; van der Donk WA
ACS Chem Biol; 2018 Apr; 13(4):951-957. PubMed ID: 29439566
[TBL] [Abstract][Full Text] [Related]
23. Immunity to lantibiotics.
Saris PE; Immonen T; Reis M; Sahl HG
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):151-9. PubMed ID: 8775975
[TBL] [Abstract][Full Text] [Related]
24. Autoinduction Specificities of the Lantibiotics Subtilin and Nisin.
Spieß T; Korn SM; Kötter P; Entian KD
Appl Environ Microbiol; 2015 Nov; 81(22):7914-23. PubMed ID: 26341212
[TBL] [Abstract][Full Text] [Related]
25. NisC binds the FxLx motif of the nisin leader peptide.
Abts A; Montalban-Lopez M; Kuipers OP; Smits SH; Schmitt L
Biochemistry; 2013 Aug; 52(32):5387-95. PubMed ID: 23869662
[TBL] [Abstract][Full Text] [Related]
26. Nisin-A lantibiotic with immunomodulatory properties: A review.
Małaczewska J; Kaczorek-Łukowska E
Peptides; 2021 Mar; 137():170479. PubMed ID: 33359393
[TBL] [Abstract][Full Text] [Related]
27. Protein engineering of lantibiotics.
Kuipers OP; Bierbaum G; Ottenwälder B; Dodd HM; Horn N; Metzger J; Kupke T; Gnau V; Bongers R; van den Bogaard P; Kosters H; Rollema HS; de Vos WM; Siezen RJ; Jung G; Götz F; Sahl HG; Gasson MJ
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):161-69. PubMed ID: 8775976
[TBL] [Abstract][Full Text] [Related]
28. Lantibiotics, class I bacteriocins from the genus Bacillus.
Lee H; Kim HY
J Microbiol Biotechnol; 2011 Mar; 21(3):229-35. PubMed ID: 21464591
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies on the fermentative production of lantibiotics by staphylococci.
Hörner T; Ungermann V; Zähner H; Fiedler HP; Utz R; Kellner R; Jung G
Appl Microbiol Biotechnol; 1990 Feb; 32(5):511-7. PubMed ID: 1366437
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics synthesized by posttranslational modification.
Hansen JN
Annu Rev Microbiol; 1993; 47():535-64. PubMed ID: 8257108
[TBL] [Abstract][Full Text] [Related]
31. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
32. Genetic determinants for the biosynthesis of nisin, a bacteriocin produced by Lactococcus lactis.
Rodríguez JM; Dodd HM
Microbiologia; 1996 Mar; 12(1):61-74. PubMed ID: 9019136
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Cross-Functionality within LanBTC Synthetase Complexes from Different Bacterial Sources with Respect to Production of Fully Modified Lanthipeptides.
Chen J; Kuipers OP
Appl Environ Microbiol; 2022 Jan; 88(2):e0161821. PubMed ID: 34788067
[TBL] [Abstract][Full Text] [Related]
34. Nisin biosynthesis and its properties.
Cheigh CI; Pyun YR
Biotechnol Lett; 2005 Nov; 27(21):1641-8. PubMed ID: 16247668
[TBL] [Abstract][Full Text] [Related]
35. Gene-encoded antibiotics made in bacteria.
Sahl HG
Ciba Found Symp; 1994; 186():27-42; discussion 42-53. PubMed ID: 7768156
[TBL] [Abstract][Full Text] [Related]
36. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.
Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl HG
Mol Microbiol; 1998 Oct; 30(2):317-27. PubMed ID: 9791177
[TBL] [Abstract][Full Text] [Related]
37. Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals.
Zhang ZJ; Wu C; Moreira R; Dorantes D; Pappas T; Sundararajan A; Lin H; Pamer EG; van der Donk WA
ACS Chem Biol; 2024 Feb; 19(2):357-369. PubMed ID: 38293740
[TBL] [Abstract][Full Text] [Related]
38. Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence.
Majchrzykiewicz JA; Lubelski J; Moll GN; Kuipers A; Bijlsma JJ; Kuipers OP; Rink R
Antimicrob Agents Chemother; 2010 Apr; 54(4):1498-505. PubMed ID: 20100873
[TBL] [Abstract][Full Text] [Related]
39. Structure and expression of a gene encoding the precursor of subtilin, a small protein antibiotic.
Banerjee S; Hansen JN
J Biol Chem; 1988 Jul; 263(19):9508-14. PubMed ID: 2837490
[TBL] [Abstract][Full Text] [Related]
40. [Lantibiotics].
Israil A
Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):1-8. PubMed ID: 1340251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
